Full Text View
Tabular View
No Study Results Posted
Related Studies
A Six Month, Safety Follow-up Study in Eosinophilic Esophagitis Subjects Who Completed Study PR-021
This study is enrolling participants by invitation only.
Study NCT01498497   Information provided by Aptalis Pharma

First Received on December 16, 2011.   Last Updated on October 31, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Eosinophilic Esophagitis
Additional conditions recognized in this trial
Esophagitis
More general conditions related to this trial
Digestive System Diseases
Eosinophilia
Esophageal Diseases
Gastroenteritis
Gastrointestinal Diseases
Hematologic Diseases
Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases
Leukocyte Disorders
Interventions listed in this trial
EUR-1100
Placebo
Sponsors listed in this trial
Aptalis Pharma


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services